High level of agreement in a fixed vs. live cell-based assay for antibodies to myelin oligodendrocyte glycoprotein in a real-world clinical laboratory setting

IntroductionAs recognition of myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease becomes more widespread, the importance of appropriately ordering and interpreting diagnostic testing for this antibody increases. Several assays are commercially available for MOG testing, and based...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Tammy L. Smith, Thomas R. Haven, Lauren M. Zuromski, Kyphuong Luong, Stacey L. Clardy, Lisa K. Peterson
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-07-01
Schriftenreihe:	Frontiers in Neurology
Schlagworte:	myelin oligodendrocyte glycoprotein (MOG) cell-based assay (CBA) MOG testing myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) demyelinating disease fixed CBA
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fneur.2023.1192644/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!